The incidence of melanoma is rising at an alarming rate and we are still awaiting an effective treatment for this malignancy. In its early stage, melanoma can be cured by surgical removal, but once metastasis has occurred there is no effective treatment. Recent findings have suggested multiple functional implications of CXCL8 and its cognate receptors, CXCR1 and CXCR2, in melanoma pathogenesis, thus underscoring their importance as targets for cancer therapy. This review provides an update on the roles of CXCL8 and its receptors in melanoma progression and metastasis. Keywords CXCL8; CXCR1; CXCR2; melanoma Chemokines are secreted, low-molecular-weight chemotactic proteins (8-11 kDa) that regulate the trafficking of leukocytes to inflammatory sites. There are more than 50 chemokines and over 20 chemokine receptors characterized, to date [1]. Chemokines have conserved cysteine residues that play important roles in their structural conformation and function. Structurally, chemokines are divided into four families based upon the position of their conserved two Nterminal cysteine-residues (CXC, CC, C and CX 3 C) [1,2]. Members of the CXC contain one amino acid between the first and second cysteine residues, CC chemokines have adjacent cysteine residues, the C subfamily has only one cysteine residue and CX 3 C chemokines have